BRIEF: Qyuns Therapeutics secures CSRC approval for full H-share circulation
Biopharmaceutical company Qyuns Therapeutics Co. Ltd. (2509.HK) announced on Tuesday that the China Securities Regulatory Commission (CSRC) has approved its plan to convert 17.32 million of its domestic shares into…
BRIEF: Coland Ocean secures CSRC approval for Hong Kong IPO
Fish oil products maker Coland Ocean Group Ltd. received a listing approval notice from the China Securities Regulatory Commission (CSRC) on Thursday, a required step for all Chinese companies seeking…
BRIEF: Ascentage Pharma gets Chinese regulatory nod for U.S. listing
Biopharmaceutical company Ascentage Pharma Group International (6855.HK) received a listing approval notice from the China Securities Regulatory Commission (CSRC) on Monday, a necessary step before it can make an overseas…
BRIEF: Rimag Group secures CSRC approval for full circulation of H-Shares
Medical imaging services provider Jiangxi Rimag Group Co. Ltd. (2522.HK) announced on Wednesday that the China Securities Regulatory Commission (CSRC) has approved its plan to convert 51.562 million of its…
Far from fast: Shein’s overseas odyssey hits fresh obstacles
The fashion retailer’s IPO ambitions are facing political pushback in Britain, while the proposed closure of a U.S. tax loophole could hurt the company’s commercial fortunes Key Takeaways: A politician…
Once branded a copycat jeweler, Zhou Liu Fu seeks gold in Hong Kong
The company, whose name resembles two popular Hong Kong rivals, has filed for a Hong Kong IPO after its application to list on China’s A-share market went nowhere Key Takeaways:…
UP Fintech reaps benefits from early move overseas
The online brokerage posted solid revenue growth in the first quarter as it gained traction in Hong Kong, its newest offshore market Key Takeaways: UP Fintech’s revenue increased 19% year-on-year…